Register Now

Upon registration you will receive an email with the webinar link to access the live event and closed captioning. Learn more about how to safelist messages.

Live Webinar

August 25, 2020 at 10 a.m. CT

What safety factors should be top of mind for a return-to-school? And what research and developments are influencing the latest thinking on this critical public health decision?

Join Wealth Management CIO Katie Nixon and Johns Hopkins epidemiologist Dr. Lisa Maragakis for a discussion on those questions as well as a general update on the COVID-19 pandemic.

Speakers

corp-nixon-katie-color-130x130-2020.jpg  

Katie Nixon
Chief Investment Officer, Wealth Management
Northern Trust


Katie is an Executive Vice President and Chief Investment Officer for the Wealth Management business at Northern Trust. In that capacity, Katie leads the national investment management practice for Northern Trust’s Wealth Management business from the firm’s Chicago headquarters. Her responsibilities include investment policy development with a particular focus on portfolio construction and implementation. She also directs the investment management activities of over 200 Northern Trust portfolio managers across the firm’s 60+ Wealth Management offices. Katie sits on the Firm’s Investment Policy Committee and Tactical Asset Allocation Committee, and she chairs the Wealth Management Investment Advisory Committee. Katie was selected as one of Private Asset Management’s ‘50 Most Influential Women in Private Wealth’ for 2016.

Prior to joining Northern Trust, Ms. Nixon worked at U.S. Trust Company for eighteen years in several investment related capacities, including Managing Director and Division Manager in the Wealth Management Division in New York, overseeing a group of portfolio managers and client service officers with total combined assets under management in excess of $7 Billion. Ms. Nixon also served on US Trust's Portfolio Policy Committee as well as the Private Equity Investment Committee.

Katie received her B.A. from Wellesley College and her M.B.A. in Finance from New York University, Stern School of Business where she graduated with distinction, Beta Gamma Sigma, and was a Stern Scholar. She has received the designations of both Certified Investment Management Analyst (CIMA®) and Certified Private Wealth Advisor (CPWA®) from the Investment Management Consultants Association. Further, she has been awarded the Chartered Financial Analyst (CFA) designation, and is also a member of the New York Society of Security Analysts and the Investment Management Consultants Association (IMCA).

wm-john-hopkins-maragakis-lisa-130x130.jpg  

Lisa Maragakis, MD, MPH, FSHEA, FIDSA
Johns Hopkins Health System Senior Director of Healthcare Epidemiology and Infection Prevention


Lisa Maragakis is an Associate Professor of Medicine at The Johns Hopkins University School of Medicine where she received her medical degree and post-doctoral Infectious Diseases training and a master’s degree in public health from The Johns Hopkins University Bloomberg School of Public Health. She serves as Senior Director for Healthcare Epidemiology and Infection Prevention for the Johns Hopkins Health System in Baltimore, Maryland. Dr. Maragakis is the Executive Director of the Biocontainment Unit at the Johns Hopkins Hospital. She serves as Co-Chair of the Healthcare Infection Control Practices Advisory Committee (HICPAC) for the Centers for Disease Control and Prevention, and as Co-Chair for the 2020 update of the SHEA-IDSA Compendium of Strategies to Prevent Healthcare Associated Infections. Her research interests integrate infection prevention, human factors engineering, implementation science, and mathematical modeling approaches to develop new interventions to prevent the transmission of high-consequence pathogens in healthcare settings.